Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.63
-0.06 (-3.55%)
At close: Jun 13, 2025, 3:59 PM
1.63
0.00%
After-hours: Jun 13, 2025, 05:50 PM EDT
-3.55%
Bid 1.62
Market Cap 18.44M
Revenue (ttm) 5.7M
Net Income (ttm) -12.78M
EPS (ttm) -1.19
PE Ratio (ttm) -1.37
Forward PE -0.94
Analyst Strong Buy
Ask 1.85
Volume 169,185
Avg. Volume (20D) 102,839
Open 1.68
Previous Close 1.69
Day's Range 1.58 - 1.70
52-Week Range 0.95 - 5.99
Beta 1.45

About MRKR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+33.33%
Marker Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
5 months ago
-7.44%
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.
No News article available yet